Creel, García-Cuéllar, Aiza y Enríquez, S.C.‘s dynamic and diverse life sciences practice is a product of the firm’s efforts to develop this area from a transactional-focused ancillary group into a fully-fledged industry group with capability across a variety of areas. In relation to pharmaceuticals, healthcare, cosmetics, medical devices, biotech, and food and beverages, the team advises on regulated activities that are relevant throughout the full product cycle, from clinical trials, to manufacturing, through packaging, advertising and marketing, to commercialisation and the export of products and services. As a substantial full-service domestic firm, significant M&A in the sector is also a notable strength. The ’pragmatic and helpful‘ counsel Guillermo Govela specialises in health regulation and administrative law, and co-leads the life sciences department with Leonel Pereznieto, who has more of a transactional focus and is also an insurance law expert. Former senior associate David Campos left the firm in April 2024.
Legal 500 Editorial commentary
- Profile
Testimonials
Collated independently by Legal 500 research team.
‘Experience working with regulatory institutions that have managed to translate into knowledge of value for clients.’
‘Great experience not only working as advisors, but by having members who were government officials on their team, their input always goes beyond the legal frame. This allows us to provide options, always aligned with the legal framework, that are not found in other offices.’
‘Creel is very well known regionally and has great expertise and experience in life science work.’
‘Guillermo Govela is a great resource who is pragmatic and helpful in finding solutions.’
Key clients
- Campbell’s de México
- Bristol Myers Squibb de Mexico
- Acino International
- General Atlantic Service Company
- Compass Group
- TekniPlex
- Japan Tobacco International México
- Stock Spirits
- 3M México
Work highlights
- Assisted a UK-based global pharmaceutical company on an examination of specific end-to-end processes.
- Advised Acino International on its acquisition of M8 Pharmaceuticals, a specialty biopharmaceutical company based in Mexico City.
- Advising Bristol Myers Squibb de Mexico on the review of health complaints for counterfeit drugs submitted before COFEPRIS.
Lawyers
Next generation partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
David Campos
Practice head
Leonel Pereznieto; Guillermo Govela